Nicholas Baxter - Sep 1, 2021 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Nicholas Baxter/
Stock symbol
LEXX
Transactions as of
Sep 1, 2021
Transactions value $
$0
Form type
4
Date filed
9/2/2021, 01:32 PM
Previous filing
Aug 30, 2021
Next filing
Mar 8, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 11K Sep 1, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +1.9K +29.23% $0.00 8.4K Sep 1, 2021 Common Shares 1.9K $6.23 Direct
holding LEXX Stock Options 1.5K Sep 1, 2021 Common Shares 1.5K $5.31 Direct
holding LEXX Stock Options 6.5K Sep 1, 2021 Common Shares 5K $7.08 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.